Novo CEO pressed by Senate to chop price ranges of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would look at new talks with insurers with regard to the checklist charges of Wegovy and copyright if they pledge to maintain the medicines on their formularies. Previously https://busch-light-peach-nutriti86531.qowap.com/90110653/healthcare-news-secrets